What is Vietnam Medicinal Materials JSC 9-Day RSI?
Vietnam Medicinal Materials JSCHSTC:DVM 32 9-Day RSI is 31.98 as of Jul. 07, 2026. GuruFocus rates HSTC:DVM with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,047 Drug Manufacturers companies, Vietnam Medicinal Materials JSC ranks better than 93.7% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Vietnam Medicinal Materials JSC 9-Day RSI Related Terms
HSTC:DVM vs ZTS, UTHR, VTRS: 9-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vietnam Medicinal Materials JSC's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vietnam Medicinal Materials JSC 9-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vietnam Medicinal Materials JSC's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Vietnam Medicinal Materials JSC's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vietnam Medicinal Materials JSC (HSTC:DVM) has a 9-Day RSI of 31.98 as of Jul. 07, 2026. According to the industry distribution chart, Vietnam Medicinal Materials JSC ranks #66 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 6.3%.
Is Vietnam Medicinal Materials JSC's 9-Day RSI too high?
Vietnam Medicinal Materials JSC's current 9-Day RSI is 31.98. The Drug Manufacturers industry median 9-Day RSI is 54.44. Vietnam Medicinal Materials JSC's value of 31.98 is 41.3% below this industry median. Based on the distribution chart, Vietnam Medicinal Materials JSC ranks #66 out of 1047 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vietnam Medicinal Materials JSC has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Vietnam Medicinal Materials JSC's 9-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vietnam Medicinal Materials JSC ranks #66 out of 1047 companies for 9-Day RSI. This places Vietnam Medicinal Materials JSC in the top 6% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 54.44. Vietnam Medicinal Materials JSC's value of 31.98 is 41.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 54.44, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vietnam Medicinal Materials JSC's current 9-Day RSI of 31.98 is 41.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 54.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vietnam Medicinal Materials JSC's current 9-Day RSI is 31.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vietnam Medicinal Materials JSC stock overvalued right now?
Vietnam Medicinal Materials JSC (HSTC:DVM) has a current 9-Day RSI of 31.98. The current 9-Day RSI is 31.98 and 41.3% below the Drug Manufacturers industry median of 54.44. Vietnam Medicinal Materials JSC's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Vietnam Medicinal Materials JSC (HSTC:DVM), the current 9-Day RSI is 31.98 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vietnam Medicinal Materials JSC Business Description
Vietnam Medicinal Materials JSC is a company specializing in clean medicinal herbs and is committed to pharmaceuticals and health food products derived from natural medicinal herbs, with product quality as a top priority. Its business areas are the production and wholesale of medicinal herbs. Its activities include manufacturing and trading of pharmaceuticals, cultivation and processing of medicinal herbs, dietary supplements, wholesale and retail of medical products, cosmetics and equipment, and import and export of goods traded by the company. Its products are developed from standardized medicinal herbs under controlled cultivation, harvesting and processing, combining traditional remedies with science under strict quality control.
32GF Score
Get the complete analysis for HSTC:DVM
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVM has been successfully added to your 